Associated Papers
Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndrome.
Russo EE et al.
Embo Molecular Medicine, 2026
Dopamine Transporter Deficiency Syndrome: A Rare Case of Infantile-Onset Dystonia-Parkinsonism.
Madduluri B et al.
Journal of Movement Disorders, 2025
40262646 (PubMed )
Supplement: jmd-25057-Supplementary-Table-1.pdf
Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the Clinical Phenotype and Precision Medicine Approaches.
Ng J et al.
Cells, 2023
The 2022 Lady Estelle Wolfson lectureship on neurofilaments.
Petzold A
Journal of Neurochemistry, 2022
The dopamine transporter gene SLC6A3: multidisease risks.
Reith MEA et al.
Molecular Psychiatry, 2022
Molecular and Clinical Repercussions of GABA Transporter 1 Variants Gone Amiss: Links to Epilepsy and Developmental Spectrum Disorders.
Fischer FP et al.
Frontiers in Molecular Biosciences, 2022
Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.
Bhat S et al.
Pharmacology & Therapeutics, 2021
Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters.
Bhat S et al.
Acs Pharmacology & Translational Science, 2021
Latch and trigger role for R445 in DAT transport explains molecular basis of DTDS.
Reith MEA et al.
Bioorganic & Medicinal Chemistry Letters, 2018
Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism.
Asjad HMM et al.
The Journal of Biological Chemistry, 2017
Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML et al.
Biochemical Pharmacology, 2017
A Caenorhabditis elegans model to study dopamine transporter deficiency syndrome.
Illiano P et al.
The European Journal of Neuroscience, 2017
Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.
Beerepoot P et al.
The Journal of Biological Chemistry, 2016
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
Mergy MA et al.
Neurochemistry International, 2014
'That DAT' gene that causes dystonia-parkinsonism: broadening the phenotype.
Bhatia KP
Brain : a Journal of Neurology, 2014
Select a paper to view details